Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Bone and parathyroid inhibitory effects of S-2(3-aminopropylamino)ethylphosphorothioic acid. Studies in experimental animals and cultured bone cells

Journal Article · · J. Clin. Invest.; (United States)
DOI:https://doi.org/10.1172/JCI111815· OSTI ID:5123983
S-2-(3-aminopropylamino)ethylphosphorothioic acid (WR 2721) is a radio- and chemoprotective agent which produces hypocalcemia in humans. Intravenous injection of 30 mg/kg WR 2721 in rats and 15 mg/kg in dogs lowers serum calcium by 19 and 25%, respectively. Hypocalcemia in dogs is associated with a fall in serum immunoreactive parathyroid hormone (PTH), which suggests that the mechanism of its hypocalcemic effect is acute hypoparathyroidism. Despite this effect on PTH, in eight chronically parathyroidectomized rats on a low phosphate diet, WR 2721 reduced serum calcium from 9.4 to 7.7 mg/dl at 3 h. Furthermore, in dogs rendered hypercalcemic by continuous infusion of PTH, WR 2721 reduced serum calcium from 11.0 to 10.6 mg/dl. To determine whether WR 2721 causes hypocalcemia by enhancing the exit of calcium from the circulation or inhibiting its entry, the drug was infused 3 h after administration of /sup 45/Ca to rats. WR 2721 did not significantly increase the rate of disappearance of /sup 45/Ca from the circulation even though serum calcium fell by 19%. In incubations with fetal rat long bone labeled in utero with /sup 45/Ca, 10(-3) M WR 2721 inhibited PTH-stimulated, but not base-line release of /sup 45/Ca. Bone resorption by primary culture of chick osteoclasts was inhibited by WR 2721 at concentrations as low as 10(-4) M in the absence of hormonal stimulation. These studies suggest that WR 2721 lowers serum calcium predominantly by blocking calcium release from bone. This acute hypocalcemic effect is at least in part independent of its effect on the parathyroid glands, and is most likely a direct effect of the agent on bone resorption.
Research Organization:
Univ. of Pennsylvania School of Medicine, Philadelphia
OSTI ID:
5123983
Journal Information:
J. Clin. Invest.; (United States), Journal Name: J. Clin. Invest.; (United States) Vol. 4; ISSN JCINA
Country of Publication:
United States
Language:
English

Similar Records

Gallium nitrate inhibits calcium resorption from bone and is effective treatment for cancer-related hypercalcemia
Journal Article · Tue May 01 00:00:00 EDT 1984 · J. Clin. Invest.; (United States) · OSTI ID:6748012

WR-2721 inhibits parathyroid adenylate cyclase
Journal Article · Sat Jan 31 23:00:00 EST 1987 · Am. J. Physiol.; (United States) · OSTI ID:6409786

Hypocalcemia and inhibition of parathyroid hormone secretion after administration of WR-2721 (a radioprotective and chemoprotective agent)
Journal Article · Wed Nov 09 23:00:00 EST 1983 · N.Engl. J. Med.; (United States) · OSTI ID:7011611